Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
- Vinorelbine after prior treatment with eribulin for advanced breast cancer: a single-centre experience suggesting cross-resistance.Clin Breast Cancer. 2022; (S1526-8209(22)00113-6)
- The prolonged clinical benefit with metronomic chemotherapy (VEX regimen) in metastatic breast cancer patients.Anticancer Drugs. 2022; 33: e628-e634